WeVote
Log In

Bill

Bill

HB 1348

Pharmaceutical Services, Office of; establishes in Department of General Services, report.

2025 Regular Session Introduced by Destiny LeVere Bolling

Virginia would establish a Pharmaceutical Services Office in the Department of General Services to centralize state drug procurement and management with a required implementation report.

Left in Appropriations
0
WeVote Research Nonpartisan
Bill Summary · HB 1348

Legislative bill overview

HB 1348 proposes establishing a Pharmaceutical Services Office within Virginia's Department of General Services and requires a report on its implementation. The bill aims to create a centralized state entity to manage pharmaceutical procurement and related services across state government operations.

Why is this important

Pharmaceutical costs represent a significant portion of state healthcare spending. A dedicated office could potentially leverage bulk purchasing power to negotiate better drug prices, standardize procurement practices, and reduce overall medication expenses for state employees, retirees, and programs like Medicaid.

Potential points of contention

  • Cost and funding uncertainty: The bill requires an appropriations commitment for a new office, and the fiscal impact statement suggests implementation costs that may compete with other budget priorities during tight budget years
  • Jurisdictional overlap: Questions remain about how this office would coordinate with existing pharmacy benefit managers, Medicaid, and the Department of Health who already manage pharmaceutical services in different contexts
  • Scope ambiguity: The bill's language about what specific services and procurement responsibilities the new office would handle leaves implementation details unclear, potentially creating administrative confusion

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.